Christopher Mesick, MD
Otolaryngology · Chevy Chase, MDNPI 1154394708
Payments from drug & device makers
Across 97 payments — averaging $20.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$615
- Optinose US, Inc.$439
- Regeneron Healthcare Solutions, Inc.$297
- GSK$263
- Kaleo, Inc.$126
- Aerin Medical Inc.$79
- plus $186 from 7 others
What the payments were for
- Food & beverage$2,005100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 26 | $615 |
| Optinose US, Inc. | 29 | $439 |
| Regeneron Healthcare Solutions, Inc. | 12 | $297 |
| GSK | 11 | $263 |
| Kaleo, Inc. | 7 | $126 |
| Aerin Medical Inc. | 3 | $79 |
| Integra Lifesciences Corporation | 2 | $72 |
| Hikma Pharmaceuticals USA | 2 | $31 |
| Alk-abello, Inc | 1 | $24 |
| Amgen | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Merck | 1 | $15 |
| Acclarent, Inc | 1 | $12 |
How this compares
$2,005 in reported general payments places this provider in the 65th percentile of 222 otolaryngology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olopatadine Hcl | 46 | $7,465 |
| Ipratropium Bromide | 60 | $2,610 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 11 | $1,387 |
| Cefdinir | 68 | $1,341 |
| Azelastine Hcl | 34 | $1,173 |
| Fluocinolone Acetonide Oil | 19 | $1,157 |
| Pantoprazole Sodium | 68 | $925 |
| Prednisone | 105 | $328 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 15 | $303 |
| Mupirocin | 15 | $118 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Chevy Chase
- Seth OringherChevy Chase$429K
- Natalie EarlChevy Chase$14K
- Philip SchoenfeldChevy Chase$5K
- Jack WilliamsChevy Chase$4K
- Jessica ShenChevy Chase$4K
- Thomas WinklerChevy Chase$3K
- Joshua LevyBethesda$873K
- Jean KimBaltimore$613K
- Douglas RehLutherville Timonium$561K
- Wojciech MydlarzBethesda$534K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.